CASI Pharmaceuticals
CASI
#10569
Rank
NZ$7.46 M
Marketcap
NZ$0.36
Share price
0.00%
Change (1 day)
-90.03%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.85. In 2024 the company made an earnings per share (EPS) of NZ-$4.48 a decrease over its 2023 EPS that were of NZ-$3.54.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.653.71%
2024NZ-$4.4826.73%
2023NZ-$3.54-32.89%
2022NZ-$5.2711.9%
2021NZ-$4.71-38.44%
2020NZ-$7.66-8.96%
2019NZ-$8.4150%
2018NZ-$5.6177.78%
2017NZ-$3.155.88%
2016NZ-$2.98-22.73%
2015NZ-$3.85-76.09%
2014NZ-$16.12318.18%
2013NZ-$3.85-71.79%
2012NZ-$13.6665.96%
2011NZ-$8.23-50%
2010NZ-$16.47-18.97%
2009NZ-$20.32-63.64%
2008NZ-$55.883.57%
2007NZ-$53.96-60.56%
2006NZ-$136.8297.22%
2005NZ-$69.37-2.7%
2004NZ-$71.30-45.59%
2003NZ-$131.03-61.8%
2002NZ-$343.00-25.52%
2001NZ-$460.55-21.38%
2000NZ-$585.8013.86%
1999NZ-$514.50149.53%
1998NZ-$206.1998.15%
1997NZ-$104.0610.2%
1996NZ-$94.42